Exelon Corporation $EXC Shares Sold by Payden & Rygel

Payden & Rygel lowered its holdings in Exelon Corporation (NASDAQ:EXC) by 98.2% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,110 shares of the company’s stock after selling 282,200 shares during the period. Payden & Rygel’s holdings in Exelon were worth $206,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in Exelon in the 2nd quarter valued at approximately $5,583,709,000. Lazard Asset Management LLC grew its stake in shares of Exelon by 6.4% in the first quarter. Lazard Asset Management LLC now owns 24,620,304 shares of the company’s stock worth $1,206,887,000 after acquiring an additional 1,490,251 shares in the last quarter. GQG Partners LLC acquired a new position in shares of Exelon in the second quarter worth $922,917,000. Legal & General Group Plc purchased a new stake in shares of Exelon during the second quarter worth $602,760,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Exelon during the second quarter worth $580,842,000. 80.92% of the stock is owned by hedge funds and other institutional investors.

Exelon Price Performance

Shares of NASDAQ EXC opened at $46.16 on Friday. The company has a debt-to-equity ratio of 1.71, a quick ratio of 0.99 and a current ratio of 1.09. Exelon Corporation has a fifty-two week low of $39.73 and a fifty-two week high of $50.65. The firm has a market capitalization of $47.65 billion, a PE ratio of 16.91, a price-to-earnings-growth ratio of 2.51 and a beta of 0.30. The stock’s 50-day simple moving average is $42.85 and its 200-day simple moving average is $45.57.

Exelon (NASDAQ:EXC) last posted its earnings results on Friday, October 30th. The company reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.08. Exelon had a return on equity of 9.81% and a net margin of 10.99%. The firm had revenue of $7.32 billion during the quarter, compared to analysts’ expectations of $6.76 billion. During the same quarter in the previous year, the business earned $0.86 earnings per share. The firm’s revenue was up 9.2% compared to the same quarter last year. As a group, equities research analysts forecast that Exelon Corporation will post 2.86 EPS for the current fiscal year.

Exelon News Summary

Here are the key news stories impacting Exelon this week:

• Positive Sentiment: Adjusted earnings and revenue beat expectations: Exelon reported third-quarter adjusted operating earnings of $0.87 per diluted share, above the $0.79 consensus estimate, while revenue rose 9.2% year over year to $7.32 billion, exceeding the $6.76 billion forecast. Higher utility rates, increased sales and infrastructure investments supported the results. Exelon Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Dividend remains intact: Exelon declared a quarterly dividend of $0.42 per share, payable December 15 to shareholders of record December 4. The payout reinforces the appeal of the regulated utility’s stable cash-flow profile. Exelon Declares Dividend
• Neutral Sentiment: Regulated utility model provides visibility: Industry commentary highlights Exelon’s predictable earnings and cash flows from regulated rates and long-term arrangements, though the comparison with PPL does not represent a company-specific catalyst. PPL vs. EXC Utility Comparison
• Negative Sentiment: GAAP earnings declined: GAAP diluted EPS fell to $0.70 from $0.86 a year earlier, despite higher revenue. Exelon also narrowed its 2026 adjusted operating earnings guidance to $2.85–$2.91 per share, signaling a tighter range for investors to monitor. Exelon Reports Third-Quarter Results

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. Morgan Stanley reduced their price objective on Exelon from $50.00 to $49.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 21st. Truist Financial lowered their target price on Exelon from $48.00 to $46.00 and set a “hold” rating for the company in a research note on Friday, October 16th. KeyCorp raised Exelon from an “underweight” rating to a “sector weight” rating and set a $41.00 target price for the company in a research note on Monday, October 12th. BMO Capital Markets cut their price target on Exelon from $47.00 to $45.00 and set a “market perform” rating on the stock in a report on Thursday, October 22nd. Finally, Scotiabank decreased their price objective on Exelon from $47.00 to $44.00 and set a “sector perform” rating for the company in a research note on Wednesday, September 30th. Six analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Exelon has a consensus rating of “Hold” and a consensus target price of $48.58.

Exelon Profile

Exelon Corporation (NASDAQ:EXC) is a regulated utility holding company that delivers electricity and natural gas to residential, commercial and industrial customers. The company operates through six utility subsidiaries: Atlantic City Electric, Baltimore Gas and Electric, Commonwealth Edison, Delmarva Power, PECO and Pepco. Its businesses focus primarily on the transmission, distribution and delivery of energy rather than owning competitive power-generation operations.

Exelon’s utilities serve customers across Illinois, Pennsylvania, Maryland, Delaware, New Jersey and the District of Columbia.